Factor XIII Concentrate (Human) and Linagliptin and Metformin Extended-Release Tablets
Determining the interaction of Factor XIII Concentrate (Human) and Linagliptin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: factor XIII
Brand name: Corifact, Tretten
Synonyms: Factor XIII, Factor XIII A-Subunit (Recombinant)
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Factor XIII Concentrate (Human)-Linagliptin and Metformin Tablets
- Factor XIII Concentrate (Human)-Lincocin
- Factor XIII Concentrate (Human)-Lincomycin
- Factor XIII Concentrate (Human)-Lincomycin Hydrochloride
- Factor XIII Concentrate (Human)-Lincomycin Injection
- Factor XIII Concentrate (Human)-Lincomycin Oral, Injection
- Linagliptin and Metformin Extended-Release Tablets-Factor xiii Intravenous
- Linagliptin and Metformin Extended-Release Tablets-Factrel
- Linagliptin and Metformin Extended-Release Tablets-FaLessa
- Linagliptin and Metformin Extended-Release Tablets-FaLessa Kit
- Linagliptin and Metformin Extended-Release Tablets-Fallback Solo
- Linagliptin and Metformin Extended-Release Tablets-Falmina